Clinical Classification of Pain in Breast Cancer Survivors
Launched by KUTAHYA HEALTH SCIENCES UNIVERSITY · Jan 2, 2020
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • diagnosed with histologically confirmed invasive or non-invasive primary breast cancer
- • completed remission and their primary treatment at least 3 months prior to study participation
- • experienced pain or a sensitive disorder (like numbness, tingling, etc.) anywhere in body for which they stated a minimum score of 3 on a numeric pain rating scale
- Exclusion Criteria:
- • patients affected by other chronic disease,
- • severe psychological disorders
- • active metastases
About Kutahya Health Sciences University
Kutahya Health Sciences University is a premier academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading researchers and healthcare professionals to conduct cutting-edge studies aimed at improving health outcomes. With a focus on translating scientific discoveries into practical applications, Kutahya Health Sciences University plays a vital role in shaping the future of healthcare through rigorous clinical research and interdisciplinary collaboration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kütahya, Kutahya Health Sciences University, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials